Protocolo diagnóstico y terapéutico de la depresión
- Pereira Sánchez, V. 1
- Molero Santos, P. 1
- 1 Departamento de Psiquiatría y Psicología Médica. Clínica Universidad de Navarra. Pamplona, Navarra, España
ISSN: 0304-5412
Year of publication: 2019
Issue Title: Enfermedades psiquiátricas (III) Psicosis. Trastornos del humor
Series: 12
Issue: 86
Pages: 5070-5074
Type: Article
More publications in: Medicine: Programa de Formación Médica Continuada Acreditado
Sustainable development goals
Abstract
When adequate therapeutic measures are implemented, the response rates of depressive disorders, despite being a major cause of discomfort, disability and suicide, are acceptable. Diagnosis is based on anamnesis, detailed psychopathological exploration and data collection from third persons, if possible. In order to rule out general medical conditions, complementary tests can be requested. It is mandatory to determine the severity of the condition by assessing the impact of the symptoms and the risk of harm to oneself or third parties. Treatment has to be consistent with the severity of symptoms, personalized to each patient and based on scientific evidence. Hygienic-dietetic guides, psychotherapy, pharmacological treatments, neuromodulation therapies and functional rehabilitation, are included in the therapeutic measures. Two algorithms for clinical decision making are included in the present protocol.
Bibliographic References
- Barth J, Munder T, Gerger H, Nüesch E, Trelle S, Znoj H. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: a network meta-analysis. PLoS Med. 2013; 10(5):e1001454.
- Bech P. Rating scales in depression: limitations and pitfalls. Dialogues Clin Neurosci. 2006;8(2):207-15.
- Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-66.
- McLaughlin KA. The public health impact of major depression: a call for interdisciplinary prevention efforts. Prev Sci. 2011;12(4):361-71.
- Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sánchez E, Gutiérrez-Rojas L, Meana JJ. Antidepressant efficacy and tolerability of ketamine and esketamine: a critical review. CNS Drugs. 2018;32(5): 411-20
- Stahl SM. Stahl’s essential psychopharmacology : neuroscientific basis and practical application. Cambridge, UK: Cambridge University Press; 2013. p. 608.
- Taylor D, Barnes TRE, Young AH, Allan H. The Maudsley prescribing guidelines in psychiatry. Chichester, West Sussex: Wiley-Black Well; 2012. p. 854.